ANTIOXIDANT STUDY MODELED ON "DRUG TREATMENT" DESIGN
This article was originally published in The Tan Sheet
Executive Summary
ANTIOXIDANT STUDY MODELED ON "DRUG TREATMENT" DESIGN may not be a "true test" of the micronutrients' chemopreventive properties given the "long latency period" of cancer, the Council for Responsible Nutrition said in response to the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study results published in the April 14 New England Journal of Medicine.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning